Equity Radar US portfolio

Peter Garnry

Head of Equity Strategy, Saxo Bank Group
Peter Garnry joined Saxo in 2010 and is Head of Equity Strategy. In 2016, he became responsible for the quantitative strategies team, which focuses on how to apply computer models to financial markets. He develops trading strategies and analyses of the equity markets as well as individual company stocks applying statistics and models.

As readers may have noticed, we have begun tracking our top 20 US equity picks in our Equity Radar model that we often use in webinars, the morning call and presentations. The portfolio was off to a strong start in June, up 5% as of June 6, but the pressure from the escalating trade war between the US and China hit the portfolio’s semiconductor holdings.

Red Hat also delivered a disappointing earnings release with a billings shortfall that took the market by surprise given the consensus that Red Hat has a very attractive long-term outlook. As of yesterday the portfolio is down 0.26% with the benchmark S&P 500 up 0.53%. Since inception the portfolio is up 0.07% with the S&P 500 up 0.05%

Source: Bloomberg

July portfolio rebalancing

Based on changing scores in our Equity Radar model, nine stocks are leaving the portfolio. Below is an overview of the changes.

Selling: ABIOMED, Best Buy, Cisco, DXC Technology, Garmin, NetApp, Red Hat, S&P Global, State Street
Buying: Micron Technology, HollyFrontier, H&R Block, KLA-Tencor, Intel, Valero Energy, Ralph Lauren, Expeditors International of Washington, IPG Photonics

The current portfolio is still dominated by IT stocks but today’s rebalancing means that two energy companies (Valero Energy and HollyFrontier) are entering the portfolio which is a natural extension of the bull market in global energy stocks.  The portfolio characteristics are concentrated around high quality, high momentum and high reversal scores.

Top 20 US equities in our Equity Radar model:

Source: Bloomberg, Saxo Bank

Access both platforms from your single Saxo account.

Disclaimer

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice or a personal recommendation and does not take into consideration your objectives, financial situation and needs. Saxo Capital Markets UK Limited will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information. We assume no liability for errors, inaccuracies or omissions contained within these materials.

It is important that you understand that with investments, your capital is at risk. We offer leveraged products which carry risk and can result in losses that exceed deposits. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more here.

Additional Key Information Documents are available in our trading platform.

Saxo Capital Markets UK is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871

Please read our full disclaimer - https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer